Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy
- 20 May 2005
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 12 (12) , 954-962
Abstract
NK4 is an hepatocyte growth factor (HGF)-antagonist and a broad angiogenesis inhibitor. NK4 gene therapy has confirmed antitumor efficacy on cancers with intact HGF-cMET signaling pathway. However, the feasibility to treat tumors in which the effect of the HGF-cMET signaling pathway is less unambiguous or may even be inhibitory on carcinogenesis, such as hepatocellular carcinoma (HCC) with NK4 needs further assessment. Therefore, we evaluated the effects of adenoviral vector-mediated expression of NK4 on the biological behavior of a series of HCC cell lines in vitro and on HepG2 xenografts in vivo. In vitro, transduction of HCC cell lines with the replication-deficient recombinant adenoviral vector AdCMV.NK4 resulted in significant inhibition of proliferation over and above the antimitogenic effects of HGF. In addition, HGF-induced scattering and invasion through matrigel were inhibited effectively. Moreover, transduced HCC cells produced sufficient amounts of NK4 protein to achieve bystander effects involving reduced migration of nontransduced tumor cells and reduced proliferation of endothelial cells. Finally, treatment of established HepG2 xenografts with AdCMV.NK4 resulted in significant tumor growth delay and significant reduction of intratumoral microvessel density. In conclusion, NK4 gene therapy is a promising strategy to treat HCC based on the pleiotropic functions of NK4 interfering with tumor growth, invasion, metastasis and angiogenesis.Keywords
This publication has 39 references indexed in Scilit:
- Suppression of peritoneal implantation of gastric cancer cells by adenovirus vector-mediated NK4 expressionCancer Gene Therapy, 2004
- Adenoviral-mediated Gene transduction of the hepatocyte growth factor (HGF) antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude miceEuropean Journal of Cancer, 2004
- Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation modelCancer Gene Therapy, 2004
- Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus‐mediated expression of NK4The Journal of Gene Medicine, 2004
- Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude miceCancer Gene Therapy, 2002
- Tumor suppression effect using NK4, a molecule acting as an antagonist of HGF, on human gastric carcinomasCancer Gene Therapy, 2002
- Targeting Angiogenesis and HGF Function Using an Adenoviral Vector Expressing the HGF Antagonist NK4 for Cancer TherapyMolecular Therapy, 2002
- Gene expression of hepatocyte growth factor and its receptor in HCC and nontumorous liver tissuesWorld Journal of Gastroenterology, 1999
- Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factorOncogene, 1998
- Expression of HGF, Its Receptor c-met, c-myc, and Albumin in Cirrhotic and Neoplastic Human Liver TissueJournal of Histochemistry & Cytochemistry, 1997